Carisoprodol Tablet
Product Images NDC 50228-109

Product Visual Gallery

This gallery contains 5 technical images submitted to the FDA as part of the official labeling for Carisoprodol (NDC 50228-109). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sciegen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carisoprodol 350 mg 100

Label for Carisoprodol Tablets, USP, 350 mg, manufactured by ScieGen Pharmaceuticals, Inc. The label includes dosage instructions, storage conditions, and a note indicating 100 tablets per container. It features the Rx Only designation, NDC 50228-109-01, and a barcode.*

FDA Label Image

Carisoprodol 350 mg 1000

Carisoprodol Tablets USP 350 mg oral tablets packaging label from ScieGen Pharmaceuticals, Inc. The label indicates the product contains 350 mg carisoprodol per tablet, with directions for usual adult dosage and storage instructions. Quantity is 1,000 tablets, prescription only, with the NDC 50228-109-10 visible alongside a barcode.*

FDA Label Image

Carisoprodol 350 mg 500

Label for Carisoprodol Tablets USP, 350 mg oral tablets with a quantity of 500 tablets. The label includes dosage information, storage instructions, and the manufacturer, ScieGen Pharmaceuticals, Inc. It features a barcode and indicates the product is prescription only.*

FDA Label Image

Carisoprodol 350mg 30

Label for Carisoprodol Tablets USP 350 mg, a prescription oral tablet manufactured by ScieGen Pharmaceuticals, Inc. The label states the dosage strength of 350 mg per tablet, packaging of 30 tablets, and includes storage instructions specifying 20°C to 25°C (68°F to 77°F). It notes the product is Rx only and to dispense in a tight container.*

FDA Label Image

Structural Formula Of Carisoprodol (Structure)

Chemical structure of carisoprodol showing the arrangement of its atoms and bonds, including amide, ether, and alkyl groups.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.